AJP - Endo Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 291: E544-E548, 2006. First published May 16, 2006; doi:10.1152/ajpendo.00510.2005
0193-1849/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/3/E544    most recent
00510.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Otani, K.
Right arrow Articles by Han, D.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Otani, K.
Right arrow Articles by Han, D.-H.

Inhibition of calpain results in impaired contraction-stimulated GLUT4 translocation in skeletal muscle

Kenichi Otani, Kenneth S. Polonsky, John O. Holloszy, and Dong-Ho Han

Department of Medicine, Washington University School of Medicine, St. Louis, Missouri

Submitted 21 October 2005 ; accepted in final form 13 April 2006

It was previously found that transgenic mice that overexpress the calpain inhibitor calpastatin (CsTg) have an ~3-fold increase in GLUT4 protein in their skeletal muscles. Despite the increase in GLUT4, which appears to be due to inhibition of its proteolysis by calpain, insulin-stimulated glucose transport is not increased in CsTg muscles. PKB (Akt) protein level is reduced ~60% in CsTg muscles, suggesting a possible mechanism for the relative insulin resistance. Muscle contractions stimulate glucose transport by a mechanism that is independent of insulin signaling. The purpose of this study was to test the hypothesis that the threefold increase in GLUT4 in CsTg would result in a large increase in contraction-stimulated glucose transport. CAMKII and AMPK mediate steps in the contraction-stimulated pathway. The protein levels of AMPK and CAMKII were increased three- to fourfold in CsTg muscles, suggesting that these proteins are also calpain substrates. Despite the large increases in GLUT4, AMPK, and CAMKII, contraction-stimulated GLUT4 translocation and glucose transport were not increased above wild-type values. These findings suggest that inhibition of calpain results in impairment of a step in the GLUT4 translocation process downstream of the insulin- and contraction-signaling pathways. They also provide evidence that CAMKII and AMPK are calpain substrates.

adenosine monophosphate-activated protein kinase; calpastatin; calcium/calmodulin-dependent protein kinase-II



Address for reprint requests and other correspondence: D.-H. Han, Washington University School of Medicine, 4566 Scott Ave., Campus Box 8113, St. Louis, MO 63110 (e-mail: dhan{at}im.wustl.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Liu, R. B. Marchase, and J. C. Chatham
Increased O-GlcNAc levels during reperfusion lead to improved functional recovery and reduced calpain proteolysis
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1391 - H1399.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.